Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Green Plus JSCHSTC:GPC 32 3-1 Month Momentum % is 5.26% as of Sep. 12, 2026. GuruFocus rates HSTC:GPC with a GF Score™ of 32/100. The stock has 1 warning sign investors should review. Among 1,023 Drug Manufacturers companies, Green Plus JSC ranks better than 56.11% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-12), Green Plus JSC's 3-1 Month Momentum % is 5.26%.
The industry rank for Green Plus JSC's 3-1 Month Momentum % or its related term are showing as below:
HSTC:GPC's 3-1 Month Momentum % is ranked better than 56.11% of 1023
companies
in the Drug Manufacturers industry
Industry Median: 3.13
vs HSTC:GPC: 5.26
Green Plus JSC (HSTC:GPC) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Green Plus JSC 3-1 Month Momentum % Related Terms
HSTC:GPC vs ZTS, UTHR, VTRS: 3-1 Month Momentum % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Green Plus JSC's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Green Plus JSC 3-1 Month Momentum % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Green Plus JSC's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Green Plus JSC's 3-1 Month Momentum % falls into.
Green Plus JSC (HSTC:GPC) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Plus JSC (HSTC:GPC) has a 3-1 Month Momentum % of 5.26% as of Sep. 12, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Green Plus JSC and its competitors. According to the industry distribution chart, Green Plus JSC ranks #449 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 43.9%.
Is Green Plus JSC's 3-1 Month Momentum % too high?
Green Plus JSC's current 3-1 Month Momentum % is 5.26%. The Drug Manufacturers industry median 3-1 Month Momentum % is 3.13. Green Plus JSC's value of 5.26% is 68.1% above this industry median. Based on the distribution chart, Green Plus JSC ranks #449 out of 1023 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Green Plus JSC has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Green Plus JSC's 3-1 Month Momentum % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Green Plus JSC ranks #449 out of 1023 companies for 3-1 Month Momentum %. This puts Green Plus JSC in the upper half of its industry. The industry median 3-1 Month Momentum % is 3.13. Green Plus JSC's value of 5.26% is 68.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Drug Manufacturers company?
The median 3-1 Month Momentum % among Drug Manufacturers companies is 3.13, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Green Plus JSC's current 3-1 Month Momentum % of 5.26% is 68.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Green Plus JSC and its competitors. For the Drug Manufacturers industry, the median 3-1 Month Momentum % is 3.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Green Plus JSC's current 3-1 Month Momentum % is 5.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Plus JSC stock overvalued right now?
Green Plus JSC (HSTC:GPC) has a current 3-1 Month Momentum % of 5.26%. The current 3-1 Month Momentum % is 5.26% and 68.1% above the Drug Manufacturers industry median of 3.13. Green Plus JSC's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Green Plus JSC (HSTC:GPC), the current 3-1 Month Momentum % is 5.26% as of Sep. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Green Plus JSC is engaged in manufacturing and distributing pharmaceutical and herbal products. The Company was established with the mission of improving public health by providing health food products of natural origin, high quality, safe and effective. Company has also chosen to cooperate with a reputable international partner from Japan so that Vietnamese people can use high-quality functional food products at reasonable prices. In addition, Green+ constantly invests in research, product development and service improvement with a team of dedicated and experienced experts to bring truly different values.
32GF Score
Get the complete analysis for HSTC:GPC
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSTC:GPC has been successfully added to your 
